theophylline	tacrine	1	1	true	positive	Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold.  		10438	10318	10438	D013619
theophylline	tacrine	1	1	true	positive	Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold.  		10438	10318	10438	D013619
theophylline	tacrine	1	2	true	positive	Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold.  Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  		10438	10318	10438	D013619
theophylline	tacrine	1	2	true	positive	Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold.  Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  		10438	10318	10438	D013619
theophylline	tacrine	1	3	true	positive	Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold.  Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  The effect of theophylline on tacrine pharmacokinetics has not been assessed.  		10438	10318	10438	D013619
theophylline	tacrine	1	3	true	positive	Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold.  Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  The effect of theophylline on tacrine pharmacokinetics has not been assessed.  		10438	10318	10438	D013619
theophylline	tacrine	2	1	true	positive	Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold.  Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  		10438	10318	10438	D013619
theophylline	tacrine	2	1	true	positive	Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold.  Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  		10438	10318	10438	D013619
theophylline	tacrine	2	2	true	positive	Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  		10438	10318	10438	D013619
theophylline	tacrine	2	2	true	positive	Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  		10438	10318	10438	D013619
theophylline	tacrine	2	3	true	negative	Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  The effect of theophylline on tacrine pharmacokinetics has not been assessed.  		10438	10318	10438	D013619
theophylline	tacrine	2	3	true	negative	Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  The effect of theophylline on tacrine pharmacokinetics has not been assessed.  		10438	10318	10438	D013619
theophylline	tacrine	3	1	true	positive	Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold.  Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  The effect of theophylline on tacrine pharmacokinetics has not been assessed.  		10438	10318	10438	D013619
theophylline	tacrine	3	1	true	positive	Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold.  Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  The effect of theophylline on tacrine pharmacokinetics has not been assessed.  		10438	10318	10438	D013619
theophylline	tacrine	3	2	true	negative	Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  The effect of theophylline on tacrine pharmacokinetics has not been assessed.  		10438	10318	10438	D013619
theophylline	tacrine	3	2	true	negative	Therefore, monitoring of plasma theophylline concentrations and appropriate reduction of theophylline dose are recommended in patients receiving tacrine and theophylline concurrently.  The effect of theophylline on tacrine pharmacokinetics has not been assessed.  		10438	10318	10438	D013619
theophylline	tacrine	3	3	true	negative	The effect of theophylline on tacrine pharmacokinetics has not been assessed.  		10438	10318	10438	D013619
theophylline	tacrine	3	3	true	negative	The effect of theophylline on tacrine pharmacokinetics has not been assessed.  		10438	10318	10438	D013619
